OPLEZEVE Trademark

Prosecution Summary

Trademark Summary
OPLEZEVE is a standard character mark owned by Merck Sharp & Dohme B.V., a Netherlands-based BESLOTEN VENNOOTSCHAP (B.V.), covering pharmaceutical preparations in International Class 005 for treating and preventing a wide range of diseases and disorders including bone, cardiovascular, neurological, oncological, and autoimmune conditions, along with antibiotics, antivirals, anti-inflammatories, and human vaccines; it also spans Domestic Classes 006, 018, 044, 046, 051, and 052. The mark is registered on the Principal Register as of February 10, 2026, with registration number 8137192. No notable issues or legal proceedings are present.

Recent Activity
Filed on July 15, 2025 with priority claimed from a Benelux registration, the application f

Trademark Facts

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Related

• All trademarks from Merck Sharp & Dohme B.V.
• More marks in Class 005
• Search for similar marks to OPLEZEVE
• Run a clearance check
• Free USPTO trademark search